Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

If your pet had any genetic diseases or increased disease risk because of their genetics, then any clones will inherit these ...

The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a ...

With a new study in the journal Cell, researchers at Stanford University and Stockholm University have contributed to ...

Life's instructions are written in DNA, but it is the enzyme RNA polymerase II (Pol II) that reads the script, transcribing ...

Tessera Therapeutics secures $150M from Regeneron to develop gene therapy for AATD, a genetic condition affecting the lungs ...

Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, Palampur, successfully concluded a two-day workshop on ...

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.

Gene-edited crops are no safer than GMOs, and fast-tracking regulatory approval could trigger a costly backlash.

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

This academic-industry partnership reflects the need for a multidisciplinary approach to innovation in cell and gene therapy manufacturing.